Showing Results for
- Academic Journals (55)
Search Results
- 55
Academic Journals
- 55
-
From:Journal of Cancer Research and Therapeutics (Vol. 12, Issue 2) Peer-ReviewedByline: Qinyong. Hu, Qi. Wang, Hengbo. Zhu, Yi. Yao, Qibin. Song Objective: To compare the therapeutic effect of irinotecan/platinum (IP) and etoposide/platinum (EP) in treatment-naive extensive small cell lung...
-
From:Canadian Journal of Chemistry (Vol. 93, Issue 9) Peer-ReviewedWe report synthesis and solid-state NMR characterization of two [sup.17]O-labeled platinum anticancer drugs: cis-diammine(1,1cydobutane-[[sup.17][O.sub.4]]dicarboxylato)platinum(II) (carboplatin) and...
-
From:Canadian Journal of Chemistry (Vol. 87, Issue 1) Peer-ReviewedA series of chiral cis-dichloro(pyridyloxazoline) platinum(II) and palladium(II) complexes were synthesized and their reactivity towards a defined sequence of single-stranded and double-stranded DNA was investigated in...
-
From:Canadian Journal of Physiology and Pharmacology (Vol. 96, Issue 12) Peer-ReviewedThe aim of this study was to examine the interaction of [Pd (2,2'-bipyridine) (morpholinedithiocarbamate)] N[O.sub.3] and [Pt (2,2'-bipyridine)(morpholinedithiocarbamate)]N[O.sub.3] with human serum albumin under...
-
From:Journal of Chemistry (Vol. 2014) Peer-ReviewedThe effect of the preparation method of monometallic Pd and Pt and bimetallic Pd-Pt/[Al.sub.2][O.sub.3]-Ti[O.sub.2] catalysts on the hydrodesulfurization (HDS) of dibenzothiophene (DBT) was investigated in this study....
-
From:Journal of Ovarian Research (Vol. 6, Issue 1) Peer-ReviewedBackground Ovarian cancer remains an on-going challenge mainly due to the development of drug resistance and also because the cancer is likely to have metastasized at the time of diagnosis. Currently, chemotherapy...
-
From:Oncology (Vol. 22, Issue 13) Peer-ReviewedABSTRACT Over 25,000 people are diagnosed with small-cell lung cancer (SCLC) in the United States annually. SCLC is a highly aggressive tumor with a propensity for early metastases and a high case-fatality rate....
-
From:Indian Journal of Cancer (Vol. 54, Issue 1) Peer-ReviewedByline: K. Udupa, R. Rajendranath, T. Sagar INTRODUCTION: Lung cancer is most common cause of cancer death in the world. Most of the patient are diagnosed in the late stages and receive only palliative treatment. The...
-
From:PLoS ONE (Vol. 13, Issue 3) Peer-ReviewedAuthor(s): Jerry D. Monroe 1, Heidi L. Hruska 2, Hannah K. Ruggles 2, Kevin M. Williams 2, Michael E. Smith 1,* Introduction A major side-effect of platinum-based anticancer drugs is damage to auditory hair cells...
-
From:Head & Neck Oncology (Vol. 2) Peer-ReviewedBackground Symptom control is an important consideration in the choice of treatment for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients who demonstrate...
-
From:Science (Vol. 261, Issue 5122) Peer-ReviewedThere is increasing interest in the use of metal-containing compounds in medicine. This review describes several therapeutic applications, such as the use of platinum complexes in cancer chemotherapy, gold compounds in...
-
From:Journal of Cancer Research and Therapeutics (Vol. 18, Issue 1) Peer-ReviewedByline: Mesut. Yilmaz, Ahmet. Baran, Merve. Yilmaz Introduction: Lung cancer is the leading cause of cancer-related deaths, worldwide. Despite immune checkpoint inhibitors and targeted therapy have revolutionized the...
-
From:Journal of Cancer Research and Therapeutics (Vol. 14, Issue 4) Peer-ReviewedByline: Yue-Qin. Li, Xin-Yin. Zhang, Juan. Chen, Ji-Ye. Yin, Xiang-Ping. Li Aims: Platinum-based chemotherapy is considered as the first-line treatment for nonsmall cell lung cancer (NSCLC) patients. However,...
-
From:Canadian Journal of Chemistry (Vol. 90, Issue 1) Peer-ReviewedDimethylplatinum(II) complexes [Pt[Me.sub.2](NN)], with NN = diimine ligand, can react with dichloromethane or chloroform solvent to give the corresponding organoplatinum(IV) complexes [PtCl[Me.sub.2](C[H.sub.2]Cl)(NN)]...
-
From:Journal of Clinical Investigation (Vol. 123, Issue 5) Peer-ReviewedPlatinum compounds display clinical activity against a wide variety of solid tumors; however, resistance to these agents is a major limitation in cancer therapy. Reduced platinum uptake and increased platinum export are...
-
From:Canadian Journal of Chemistry (Vol. 91, Issue 2) Peer-ReviewedCondensation of 2-pyridinecarboxaldehyde with six primary amines containing aliphatic groups gave the corresponding pyridinecarboxaldimines (N-N'R). Addition of these ligands to [Pt[Cl.sub.2](coe)]2 (coe =...
-
From:PLoS ONE (Vol. 11, Issue 12) Peer-ReviewedA series of platinum(II) diiodido complexes containing 7-azaindole derivatives, having the general formula cis-[PtI.sub.2 (naza).sub.2 ] (1-8), has been prepared and thoroughly characterized, including X-ray structure...
-
From:Canadian Journal of Chemistry (Vol. 87, Issue 1) Peer-ReviewedThe preparation and characterization of cationic, dinuclear complexes of the type trans-[Pt[([PPh.sub.3]).sub.2] ([sigma]-[C.sub.6][H.sub.4]NHMe) -[mu]-L-Pt[([PPh.sub.3].sub.2]...
-
From:Nature Medicine (Vol. 23, Issue 4) Peer-ReviewedCisplatin and its platinum analogs, carboplatin and oxaliplatin, are some of the most widely used cancer chemotherapeutics. Although cisplatin and carboplatin are used primarily in germ cell, breast and lung...
-
From:PLoS ONE (Vol. 10, Issue 8) Peer-ReviewedThe cis-[PtCl.sub.2 (naza).sub.2 ] complexes (1-3) containing monosubstituted 7-azaindole halogeno-derivatives (naza), showed significantly higher activity than cisplatin towards ovarian carcinoma A2780, its...